Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and Adolescents

CONTEXT: Cardiometabolic effects of second-generation antipsychotics (SGAs) are concerning, but have been insufficiently studied in antipsychotic-naïve and pediatric patients. OBJECTIVES: To study SGAs effects on body composition and metabolic parameters, unconfounded by prior antipsychotic exposure...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Correll, Christoph U., Manu, Peter, Olshanskiy, Vladimir, Napolitano, Barbara, Kane, John M., Malhotra, Anil K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055794/
https://ncbi.nlm.nih.gov/pubmed/19861668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2009.1549
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak